Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canntab Therapeutics Ltd C.PILL

Alternate Symbol(s):  CTABF

Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Companyโ€™s operations comprise a single segment engaged in the medical marijuana business. The Companyโ€™s hard pill cannabinoid formulations provide doctors, patients, and consumers with medical grade solutions. These include once a day and extended-release formulations. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet (ODT). The IR Tablet is a release profile for solid hard tablets. The XR Tablet is a phytocannabinoid vehicle that is designed to directly address the drawbacks and challenges of competing oral delivery systems. ODT is specifically designed to dissolve directly in the patientโ€™s mouth, with an onset of action between five and thirty minutes.
๏ปฟ

CSE:PILL - Post by User

Canntab Therapeutics Ltd > FSD Pharma Receives U.S. FDA Approval ๐Ÿ’Š๐Ÿฉน๐ŸŽ‰
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by Eppyon Jun 06, 2020 9:58am
137 Views
Post# 31119836

RE:FSD Pharma Receives U.S. FDA Approval ๐Ÿ’Š๐Ÿฉน๐ŸŽ‰

RE:FSD Pharma Receives U.S. FDA Approval ๐Ÿ’Š๐Ÿฉน๐ŸŽ‰Is there a relationship between FSD and PILL?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities